Position in GANX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$21,812
New position
Shares Held
10,745
first reported quarter
Ownership
0.025%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 49 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026HARBOUR INVESTMENTS, INC. holds $3,692,478 across 135 Biotechnology names. GANX ranks #23 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
|
16,451 | $641,753 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
636 | $396,571 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
734 | $364,599 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,365 | $328,924 | |
| 5 | OMER |
Omeros Corp
|
23,139 | $220,051 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
3,533 | $192,689 | |
| 7 | STOK |
Stoke Therapeutics, Inc.
|
4,413 | $144,393 | |
| 8 | NTLA |
Intellia Therapeutics, Inc.
|
7,534 | $127,475 |
All Filings in GANX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,812 | 10,745 | Shares | Sole | 2026-08-12 | |
| No filing history on record for this holder in this stock. | ||||||